Tag Archives: infrapopliteal

balon farmacologico

Drug-Coated Balloons in Critical Ischemia: The Paradigm of Randomized Evidence vs. Logbooks

Drug-Coated Balloons in Critical Ischemia: The Paradigm of Randomized Evidence vs. Logbooks

This research, which included thousands of patients treated for chronic inferior limb ischemia with drug-coated balloons, did not show an association between said devices and the increased mortality observed in some randomized trials.  The long-term evidence from plenty of real-world patients contradicts what has been shown in randomized trials, leaving an information gap. Endovascular revascularization

balón farmacológico

Drug coated balloons: Superior in infrapopliteal territory?

Original Title: Drug-Coated Balloons for Revascularization of Infrapopliteal Arteries. A Meta-Analysis of Randomized Trials. Reference: Salvatore Cassese et al. J Am Coll Cardiol Intv. 2016. Online before print.     The aim of this study was to perform a meta-analyzis of the most relevant randomized trials on the use of drug coated balloons (DCBs) in

DES in critical ischemia caused by infrapopliteal lesions

Original Title: Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial. Reference: Marlon I. Spreen et al. Circ Cardiovasc Interv. 2016 Feb;9(2):e002376.   The treatment of infrapopliteal lesions in patients with critical limb ischemia is limited by the high rates of restenosis. The most frequent course of treatment is

Pedal arch patency, the challenge of critical limb ischemia

Original Title: Outcomes of Straight-Line Flow UIT and Without Pedal Arch in Patients UIT Critical Limb Ischemia. Reference: Akihiro Higashimori, et al. Catheterization and cardiovascular Intervention 2016;87:129-133 Courtesy of Dr. Carlos Fava. Establishing one straight line flow into a patent pedal arch in critical limb ischemia is a real challenge occasionally achieved. This study analyzed 137

Seguridad de los balones con paclitaxel en enfermedad vascular periférica

Atherectomy in Infrapopliteal Lesions with Good Results at One Year

Original Title: One-Year Outcomes Following Directional Atherectomy of Infrapopliteal Lesions: Subgroup Results of the Prospective, Multicenter DEFINITIVE LE Trial. Reference: Aljoscha Rastan, et al Journal Endovascular Therapy 2015;22:839-846 Courtesy of Dr. Carlos Fava Infrapopliteal peripheral vascular disease continues to rise, especially in patients with diabetes and kidney failure, usually presenting diffuse and fairly calcified lesions. Removing